Pharmafile Logo

company norms

Thought Leaders in Medical Affairs: Key Trends & Challenges Shaping the Future of the Medical Affairs Role

How can Medical Affairs divisions bring greater value to their organizations and practitioners every day?

Medscape Medical Affairs

Mobilizing Agitation Detection in Children with ADHD

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

Impetus Digital

- PMLiVE

Inspiring researchers to find the impossible with a next generation solution

Though BD is very well known within the immunology and flowcytometry space, there is low awareness that BD is the only brand with a true multiomics offering. BD wanted to...

Create Health

The Medscape Medical Affairs Difference

What is so different about Medscape Medical Affairs in this crowdedMedical Communications landscape?

Medscape Medical Affairs

- PMLiVE

Leveraging KOL insights to succeed in a data-driven world

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in...

Medscape Medical Affairs

- PMLiVE

Shionogi signs licence agreement with MPP for COVID-19 oral antiviral treatment

The agreement aims to increase access to ensitrelvir in low- and middle-income countries

- PMLiVE

Medscape Medical Affairs

Medscape's New Unit to Support Pharmaceutical Medical Affairs

Medscape Medical Affairs

- PMLiVE

InflaRx seeks FDA authorisation for vilobelimab for critically ill COVID-19 patients

A phase 3 study showed that the antibody reduced the all-cause mortality rate after 28 days

Modern Medical Affairs: How to Leverage Tech and Data as an MSL

Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...

Impetus Digital

- PMLiVE

Shionogi’s antiviral COVID-19 treatment meets phase 3 primary endpoint

Ensitrelvir reduced the time taken to resolve five key symptoms

- PMLiVE

WHO reports warnings of ‘COVID-19 complacency’ from countries tracking global vaccine roll-out

Vaccination rates in low-income countries stand at 19% compared to almost 75% in high-income countries

- PMLiVE

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment

Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?

Say Communications

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links